Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000570646

Apexbio Technology LLC RALTEGRAVIR-POTASSIUM-SALT-5MG
SDP

Catalog No. 5000570646
Encompass_Preferred

Raltegravir potassium salt (CAS No 871038-72-1) is a potent HIV-1 integrase inhibitor extensively investigated in biomedical research Originating as an antiretroviral agent it disrupts the integration of viral DNA into the host genome a crucial step in the viral replication cycle Its mechanism of action targets the integrase enzyme effectively blocking the strand transfer reaction essential for viral replication In vitro studies often demonstrate activity in the nanomolar range making it a vital tool in antiviral research It is commonly used in various cell models including human T lymphocytes and in vivo studies to evaluate efficacy and resistance Additionally it plays a significant role in drug screening processes for novel antiretrovirals Experimental concentrations typically depend on the specific research design ensuring relevance to the study context

Catalog No. 50-005-70646 Supplier Apexbio Technology LLC Supplier No. B47605
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Raltegravir potassium salt (CAS No 871038-72-1) is a potent HIV-1 integrase inhibitor extensively investigated in biomedical research Originating as an antiretroviral agent it disrupts the integration of viral DNA into the host genome a crucial step in the viral replication cycle Its mechanism of action targets the integrase enzyme effectively blocking the strand transfer reaction essential for viral replication In vitro studies often demonstrate activity in the nanomolar range making it a vital tool in antiviral research It is commonly used in various cell models including human T lymphocytes and in vivo studies to evaluate efficacy and resistance Additionally it plays a significant role in drug screening processes for novel antiretrovirals Experimental concentrations typically depend on the specific research design ensuring relevance to the study context

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.